4//SEC Filing
JOHNSON KENNETH ERLAND 4
Accession 0001867096-25-000023
CIK 0001867096other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:39 PM ET
Size
6.3 KB
Accession
0001867096-25-000023
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Tax Payment
Common Stock
2025-01-31$3.56/sh−15,476$55,095→ 346,288 total - Tax Payment
Common Stock
2025-01-31$3.56/sh−25,842$91,998→ 320,446 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2025.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743774
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:39 PM ET
- Size
- 6.3 KB